Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/1536012117708705 http://scihub22266oqcxt.onion/10.1177/1536012117708705 C5469514!5469514!28654386     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mol+Imaging 2017 ; 16 (ä): ä Nephropedia Template TP {{tp|p=28654386|t=2017. Dual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis |pdf=|usr=}}{{28654386}} gab.com Text Dual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis JO: Mol Imaging http://www.kidney.de/pget.php?&tw=1&pmid=28654386 #FOAvip Amyloidosis is associated with a number of rare diseases and is characterized by the deposition, in abdominothoracic organs and peripheral nerves, of extracellular protein fibrils, which leads to dysfunction and severe morbidity. Effective clinical evaluation and management of patients with systemic amyloidosis are hampered by the lack of a noninvasive, quantitative method for detecting whole-body amyloid load. We have used a battery of assays including dual-energy SPECT imaging and comparative effectiveness studies in support of translation of a synthetic polybasic peptide, p5+14, as a novel radiotracer for visualization of amyloidosis by molecular imaging. These data provide support for a phase 1 positron emission tomography/computed tomography imaging trial of this reagent, labeled with iodine-124, in patients with all forms of systemic amyloidosis. Twit Text FOAVip Dual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis ????Mol Imaging http://www.kidney.de/pget.php?&tw=1&pmid=28654386 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28654386 #FOAvip English Wikipedia <ref>{{Cite pmid|28654386}}</ref> Dual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis #MMPMID28654386 Wall JS; Kennel SJ; Martin EB Mol Imaging 2017[Jan]; 16 (ä): ä PMID28654386show ga Amyloidosis is associated with a number of rare diseases and is characterized by the deposition, in abdominothoracic organs and peripheral nerves, of extracellular protein fibrils, which leads to dysfunction and severe morbidity. Effective clinical evaluation and management of patients with systemic amyloidosis are hampered by the lack of a noninvasive, quantitative method for detecting whole-body amyloid load. We have used a battery of assays including dual-energy SPECT imaging and comparative effectiveness studies in support of translation of a synthetic polybasic peptide, p5+14, as a novel radiotracer for visualization of amyloidosis by molecular imaging. These data provide support for a phase 1 positron emission tomography/computed tomography imaging trial of this reagent, labeled with iodine-124, in patients with all forms of systemic amyloidosis. äDual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amy(epmc).pdf DeepDyve Pubget Overpricing